XML 30 R5.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statement of Changes in Stockholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Total
Balance at Dec. 31, 2023 $ 18 $ 159,143 $ (799) $ (121,022) $ 37,340
Balance (in Shares) at Dec. 31, 2023 17,950,776        
Stock-based compensation 1,779 1,779
Gain (loss) on foreign currency translation 130 130
Net loss (11,025) (11,025)
Balance at Mar. 31, 2024 $ 18 160,922 (669) (132,047) 28,224
Balance (in Shares) at Mar. 31, 2024 17,950,776        
Balance at Dec. 31, 2023 $ 18 159,143 (799) (121,022) 37,340
Balance (in Shares) at Dec. 31, 2023 17,950,776        
Gain (loss) on foreign currency translation         (237)
Net loss         (32,864)
Balance at Sep. 30, 2024 $ 22 193,575 (1,036) (153,886) 38,675
Balance (in Shares) at Sep. 30, 2024 22,172,451        
Balance at Mar. 31, 2024 $ 18 160,922 (669) (132,047) 28,224
Balance (in Shares) at Mar. 31, 2024 17,950,776        
Stock-based compensation 2,350 2,350
Common stock issued for cash 2,032 2,032
Common stock issued for cash (in Shares) 198,364        
Common stock and warrants issued for cash $ 2 13,463 13,465
Common stock and warrants issued for cash (in Shares) 1,557,592        
Gain (loss) on foreign currency translation (44) (44)
Net loss (9,746) (9,746)
Balance at Jun. 30, 2024 $ 20 178,767 (713) (141,793) 36,281
Balance (in Shares) at Jun. 30, 2024 19,706,732        
Stock-based compensation   1,719     1,719
Common stock and warrants issued for cash $ 2 12,290     12,292
Common stock and warrants issued for cash (in Shares) 2,390,022        
Reclassification from redeemable common stock   799     799
Reclassification from redeemable common stock (in Shares) 75,697        
Gain (loss) on foreign currency translation     (323)   (323)
Net loss       (12,093) (12,093)
Balance at Sep. 30, 2024 $ 22 193,575 (1,036) (153,886) 38,675
Balance (in Shares) at Sep. 30, 2024 22,172,451        
Balance at Dec. 31, 2024 $ 22 195,754 (575) (163,104) 32,097
Balance (in Shares) at Dec. 31, 2024 22,280,451        
Stock-based compensation 2,076 2,076
Common stock issued for cash $ 1 5,272 5,273
Common stock issued for cash (in Shares) 649,860        
Exercise of warrants for cash 1 1
Exercise of warrants for cash (in Shares) 100        
Gain (loss) on foreign currency translation (35) (35)
Net loss (9,739) (9,739)
Balance at Mar. 31, 2025 $ 23 203,103 (610) (172,843) 29,673
Balance (in Shares) at Mar. 31, 2025 22,930,411        
Balance at Dec. 31, 2024 $ 22 195,754 (575) (163,104) 32,097
Balance (in Shares) at Dec. 31, 2024 22,280,451        
Gain (loss) on foreign currency translation         (189)
Net loss         (40,669)
Balance at Sep. 30, 2025 $ 27 229,888 (764) (203,773) 25,378
Balance (in Shares) at Sep. 30, 2025 26,585,258        
Balance at Mar. 31, 2025 $ 23 203,103 (610) (172,843) 29,673
Balance (in Shares) at Mar. 31, 2025 22,930,411        
Stock-based compensation 1,534 1,534
Common stock issued for cash $ 4 22,267 22,271
Common stock issued for cash (in Shares) 3,654,847        
Gain (loss) on foreign currency translation (153) (153)
Net loss     (24,458) (24,458)
Balance at Jun. 30, 2025 $ 27 226,904 (763) (197,301) 28,867
Balance (in Shares) at Jun. 30, 2025 26,585,258        
Stock-based compensation   2,984     2,984
Gain (loss) on foreign currency translation     (1)   (1)
Net loss       (6,472) (6,472)
Balance at Sep. 30, 2025 $ 27 $ 229,888 $ (764) $ (203,773) $ 25,378
Balance (in Shares) at Sep. 30, 2025 26,585,258